Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $69.1800 (-2.29%) ($68.4400 - $72.0000) on Thu. Apr. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 45 | Latest Price | $69.1800(-2.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -2.4% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(32%) IBB(26%) VFMO(25%) XLV(25%) BOTZ(23%) | Factors Impacting SGEN price | SGEN will decline at least -1.385% in a week (0% probabilities). UUP(-8%) IFRA(-7%) VXX(-5%) VIXM(-3%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
Resistance Level | $75.51 | 5 Day Moving Average | $74.47(-7.1%) | 10 Day Moving Average | $76.85(-9.98%) | 20 Day Moving Average | $75.51(-8.38%) | To recent high | -14.5% | To recent low | 6.4% | Market Cap | $12.028b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |